The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: A model

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kahn, James G ^a   Jiwani, Aliya ^b   Gomez, Gabriela B ^c   Hawkes, Sarah J ^d   Chesson, Harrell W ^e   Broutet, Nathalie ^f   Kamb, Mary L ^e   Newman, Lori M ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Super Models for Global Health   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE;

ADVERSE OUTCOME; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; COST; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DELIVERY; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH IMPACT ASSESSMENT; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MATERNAL SYPHILIS TESTING; MATERNAL WELFARE; MEDICAL CARE; MORTALITY; MOTHER TO CHILD TRANSMISSION; MULTIPLE CYCLE TREATMENT; PATIENT COUNSELING; PREGNANT WOMAN; PRENATAL CARE; PRENATAL SCREENING; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; RAPID DIAGNOSTIC TEST; REAGIN TEST; SCALE UP; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; STILLBIRTH; SYPHILIS; SYPHILIS SEROLOGY; VERTICAL TRANSMISSION;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SYPHILIS, CONGENITAL;

EID: 84900399514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087510     Document Type: Article

References (36)

1. World Health Organization (2012) Investment case for eliminating mother-to-child transmission of syphilis: Promoting better maternal and child health and stronger health systems. Geneva, Switzerland.
2. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, et al. (2013) Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 91: 217-226.
3. Terris-Prestholt F, Watson-Jones D, Mugeye K, Kumaranayake L, Ndeki L, et al. (2003) Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sexually transmitted infections 79: 375-381. (Pubitemid 37330304)
4. Hawkes S, Matin N, Broutet N, Low N (2011) Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis 11: 684-691.
5. Blandford JM, Gift TL, Vasaikar S, Mwesigwa-Kayongo D, Dlali P, et al. (2007) Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa. Sexually transmitted diseases 34: S61-66. (Pubitemid 47012322)
6. Rydzak CE, Goldie SJ (2008) Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sexually transmitted diseases 35: 775-784.
7. Owusu-Edusei K, Jr., Gift TL, Ballard RC (2011) Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sexually transmitted diseases 38: 997-1003.
8. Peeling RW (2006) Testing for sexually transmitted infections: a brave new world? Sexually transmitted infections 82: 425-430.
9. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE (2011) Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC public health 11 Suppl 3: S9.
10. Gloyd S, Chai S, Mercer MA (2001) Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health policy and planning 16: 29-34. (Pubitemid 32183645)
11. Hossain M, Broutet N, Hawkes S (2007) The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies. Sexually transmitted diseases 34: S22-30. (Pubitemid 47012316)
12. World Health Organization (2007) The global elimination of congenital syphilis: rationale and strategy for action.
13. World Health Organization (2008-2011) Global Health Observatory Data Repository. Antenatal care attendees who were positive for syphilis by country.
14. World Health Organization (2008-2011) Global Health Observatory Data Repository. Antenatal care (ANC) attendees tested for syphilis at first ANC visit by country.
15. World Health Organization (2013) WHO-CHOICE. Country-specific unit costs (2008).
16. World Health Organization (2012) Choosing Interventions that are Cost Effective (WHO-CHOICE).
17. Lujan J, de Onate WA, Delva W, Claeys P, Sambola F, et al. (2008) Prevalence of sexually transmitted infections in women attending antenatal care in Tete province, Mozambique. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 98: 49-51.
18. Tinajeros F, Grossman D, Richmond K, Steele M, Garcia SG, et al. (2006) Diagnostic accuracy of a point-of-care syphilis test when used among pregnant women in Bolivia. Sexually transmitted infections 82 Suppl 5: v17-21. (Pubitemid 46293820)
19. Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka M, et al. (2002) Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. The Journal of infectious diseases 186: 940-947.
20. Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD, Jr. (1999) Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 93: 5-8.
21. World Health Organization (2008) The global burden of disease: 2004 update.
22. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global Burden of Disease and Risk Factors. Disease Control Priorities Project. Washington (DC): World Bank.
23. Jamison DT, Shahid-Salles SA, Jamison J, Lawn JE, Zupan J (2006) Chapter 6: Incorporating deaths near the time of birth into estimates of the global burden of disease. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global Burden of Disease and Risk Factors: Oxford University Press.
24. Fleming DT, Wasserheit JN (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually transmitted infections 75: 3-17. (Pubitemid 29117474)
25. Mehta SD, Ghanem KG, Rompalo AM, Erbelding EJ (2006) HIV seroconversion among public sexually transmitted disease clinic patients: analysis of risks to facilitate early identification. J Acquir Immune Defic Syndr 42: 116-122. (Pubitemid 43947956)
26. World Health Organization (2003) Guidelines for the Management of Sexually Transmitted Infections. Geneva, Switzerland.
27. Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, et al. (2012) Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA 307: 2079-2086.
28. Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, et al. (2002) Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. The Journal of infectious diseases 186: 948-957.
29. World Health Organization (2011) CHOosing Interventions that are Cost Effective (WHO-CHOICE): Cost-effectiveness thresholds.
30. The World Bank (2010) GDP per capita (current US$). World DataBank.
31. Schackman BR, Neukermans CP, Fontain SN, Nolte C, Joseph P, et al. (2007) Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med 4: e183.
32. World Health Organization (2008) Countdown to 2015: Tracking progress in maternal, newborn, and child survival: the 2008 report.
33. Hutubessy R, Chisholm D, Edejer TT (2003) Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost effectiveness and resource allocation: C/E 1: 8.
34. Montoya PJ, Lukehart SA, Brentlinger PE, Blanco AJ, Floriano F, et al. (2006) Comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma reagin test for antenatal syphilis screening in Mozambique. Bull World Health Organ 84: 97-104. (Pubitemid 43275767)
35. Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, et al. (2009) The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Applied health economics and health policy 7: 229-243.
36. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL (2004) The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspectives on sexual and reproductive health 36: 11-19. (Pubitemid 38252839)